NACE: A Urinary Footprint of Acrylonitrile and Tobacco-Smoke Exposure

This test measures N‑acetyl‑S‑(2‑cyanoethyl)‑L‑cysteine (NACE), a urinary mercapturic‑acid metabolite and exposure marker formed from acrylonitrile and related 2‑cyanoethyl electrophiles.

It reflects recent internal exposure (typically via inhalation or dermal contact) and the body’s glutathione‑conjugation detoxification of those compounds, and is used in occupational and environmental biomonitoring to estimate acrylonitrile exposure.

Consider testing if you’re a current or recent smoker, have heavy secondhand smoke exposure, work around plastics/rubber manufacturing, or live near industrial sources—N-Acetyl (2-Cyanoethyl) cysteine (NACE) is a urine marker of acrylonitrile exposure from these settings.

It’s useful for establishing a baseline and for checking whether exposure-reduction steps (e.g., quitting smoking, improving ventilation/PPE) are working—levels typically fall when exposure drops.

Results are best interpreted alongside your exposure history and other relevant toxin markers; consult a clinician if your level is elevated or symptoms persist.

Obtain a baseline test once to assess exposure to N-Acetyl (2-Cyanoethyl) cysteine (NACE); if levels are elevated, perform periodic follow-up testing (for example every few months) to monitor changes, and retest after meaningful lifestyle or environmental changes — for example "after changing household products" or "following detoxification efforts."

Several factors can affect N-Acetyl (2-Cyanoethyl) cysteine (NACE) test results: timing of sample collection (levels can vary over time), recent exposure from food, air, water or consumer products, individual metabolism (including genetic and liver function differences), hydration status (which dilutes or concentrates urine), and the sample type used (urine versus blood have different matrices); certain medications or supplements may also influence readings.

Fasting is generally not required for N‑Acetyl (2‑Cyanoethyl) cysteine (NACE) testing; this test is usually performed on urine rather than blood. A first‑morning urine sample is often recommended because it is more concentrated and reduces within‑day variability, but many labs will accept a spot urine—follow the specific instructions from your testing lab or clinician.

If possible, avoid known recent exposures to likely sources (for example handling certain plastics or industrial materials, recent use of specific personal care products, or application/nearby use of pesticides) in the 24–48 hours before sampling to reduce the chance of acute contamination, though testing should not be delayed if the goal is to measure recent exposure. Document and tell the lab or clinician about any recent product use or environmental/occupational contacts (plastics, personal care items, pesticides, solvents, smoke, etc.), as this information helps interpret results and may affect sampling timing or instructions.

Accuracy depends strongly on sample timing (collection relative to exposure and whether a spot or 24‑hour sample is used), the laboratory method (mass spectrometry–based methods are preferred over less specific assays), and consistent, proper collection, handling, and storage (including normalization practices such as creatinine adjustment when appropriate). Biological variability (metabolism, hydration) and inconsistent sampling can cause false negatives or variability, so results are best interpreted alongside exposure history and, if needed, repeat testing or complementary biomarkers.

High N-Acetyl (2-Cyanoethyl) cysteine (NACE) levels most often mean either increased recent exposure to the parent chemical(s) (for example from the environment, workplace, smoke or other lifestyle sources) or a reduced ability to clear those metabolites from the body (slower detoxification or excretion). Very high results suggest ongoing or repeated exposure, while mild elevations can reflect a single recent contact or individual metabolic differences.

Results should always be interpreted in context — alongside other toxin measurements, lifestyle factors (smoking, occupation, diet), symptoms, and clinical markers of liver/kidney function — rather than in isolation. Abnormal NACE typically prompts clinical review, consideration of repeat testing, investigation of exposure sources, and steps to reduce exposure or assess clearance if needed.

Interpret your N‑Acetyl (2‑Cyanoethyl) cysteine (NACE) result by comparing the numerical value to the laboratory’s reference range and the report’s flags (low/normal/high); a single value is rarely diagnostic on its own, so place it in the context of timing (when the sample was taken relative to possible exposures), symptoms, and any known contact with relevant chemicals. Relative elevation can reflect recent exposure or increased formation/retention, while values within the reference interval are generally less suggestive of significant recent exposure—however, exact clinical implications depend on the lab method and your medical history, so discuss abnormal results with a clinician familiar with your exposure risk and health status.

Trends over time are more informative than isolated measurements: follow-up testing that shows rising or falling NACE levels helps distinguish ongoing exposure from past exposure or clearance. Always review NACE together with related toxin markers and body‑system indicators (for example liver and kidney function tests, oxidative‑stress biomarkers, and other exposure-specific metabolites) to assess metabolism, excretion, and organ impact; use serial results and exposure history to guide further evaluation, workplace/environmental investigation, or medical management.